Pune, India -- (SBWIRE) -- 10/17/2018 -- Market Highlights:

Stem cells have a remarkable potential to develop into different types of cells and are involved in the internal repair system of the body. Stem cell assays are the techniques for analyzing the living cells on the parameters of shape, size, besides others with the aim to measure biochemical and cellular functioning of the cells. Such properties make the stem cell assays to be extensively utilized in industrial practices of drug development. Growing biotechnology sector and increasing global burden of diseases like cancer, diabetes, and others are estimated to be the major drivers for the market growth during the forecast period. According to the World Health Organization in 2017, the number of patients suffering from diabetes was estimated to be about 422 million in 2014. Moreover, WHO projected that by 2030, diabetes would be the seventh leading cause of death across the globe. Additionally, growing healthcare expenditure and rising government support boosts the market growth during the forecast period. However, factors such as stringent government policies, high procedural cost followed by lack of awareness and skilled forces will restrain the market growth during the projected period, 2017-2023. Market for Global Stem Cell Assay is estimated to grow at an approximate cagr of 19.80% from 2017 to 2023.

Get Exclusive Sample Report @ https://www.marketresearchfuture.com/sample_request/5656

Regional Analysis:

The Americas hold the largest share of global stem cell assay market. Increasing adoption of new technologies, huge patient population for diseases like diabetes, cancer and others, rising healthcare expenditure drives the market growth within the region. Europe stands second in the market. This can be attributed to the growing biotechnology sector, huge patient population, and increasing support by the government for research and development. Asia Pacific region is projected to be the fastest growing market for stem cell assay. Factors such as increasing awareness, rising healthcare expenditures, presence of the developing economies like India and China provide a favorable background for the growth of the market within the region. On the other hand, the Middle East & Africa holds the least share of the global stem cell assay market. Low per capita healthcare expenditure, lack of awareness, stringent government policies, and presence of poor economies, especially in the African region restraints the market growth within the region. A majority of the stem cell assay market within the region is held by the Middle East owing to a well-developed healthcare sector and huge healthcare expenditure in the developed economies like Saudi Arabia, Kuwait, and Qatar.

Key players of Global Stem Cell Assay Market:

- GE Healthcare (U.K.)
- Promega Corporation (U.S.)
- Thermo Fisher Scientific (U.S.)
- Merck KGaA (Germany)
- Cell Biolabs, Inc. (U.S.)
- Hemogenix (U.S.)
- STEMCELL Technologies Inc. (CA)
- Bio-Rad Laboratories, Inc. (U.S.)
- Bio-Techne Corporation (U.S.)
- Cellular Dynamics International Inc. (U.S.), and others.

Segments:

The global stem cell assay market is segmented on the basis of product, technology, assay, application, and end-user. On the basis of the product, the market is categorized into micro electrode arrays, flow cytometer, cell imaging systems, automated cell counter, kits, and others. The kits segment is sub segmented into mesenchymal stem cell kits, induced pluripotent stem cell kits, umbilical cord stem cells, and others. On the basis of the technology, the market is segmented into micro fabricated assisted technology microfluidics based cell trap technologies, and others. On the basis of the assay, the market is segmented into cell viability & toxicity assays, cell identification assays, cell proliferation assays, cell apoptosis assays, and others. On the basis of the application, the market is segmented into orthopedic & musculoskeletal spine, dermatology, cardiovascular, central nervous system, and others. On the basis of the end user, the market is segmented into biotechnology industries, research organizations, academic institutes, and others.

Avail Amazing Discount on Report @ https://www.marketresearchfuture.com/check-discount/5656

BRIEF TOC:

Chapter 1. Report Prologue

Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations

Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation

LIST OF TABLES
Table 1 Stem Cell Assay Industry Synopsis, 2017 – 2023
Table 2 Global Stem Cell Assay Market Estimates And Forecast, 2017 – 2023, (USD Million)
Table 3 Global Stem Cell Assay Market By Region, 2017 – 2023, (USD Million)
Table 4 Global Stem Cell Assay Market By Product, 2017 – 2023, (USD Million)
Table 5 Global Stem Cell Assay Market By Technology, 2017 – 2023, (USD Million)
Table 6 Global Stem Cell Assay Market By Assay, 2017 – 2023, (USD Million)
Table 7 Global Stem Cell Assay Market By Application, 2017 – 2023, (USD Million

LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Global Stem Cell Assay Market
Figure 3 Market Dynamics For Global Stem Cell Assay Market
Figure 4 Global Stem Cell Assay Market Share, By Product 2016
Figure 5 Global Stem Cell Assay Market Share, By Technology 2016
Figure 6 Global Stem Cell Assay Market Share, By Assay, 2016
Figure 7 Global Stem Cell Assay Market Share, By Application, 2016

…TOC CONTINUED

Have a Question Ask to Our Experts @ https://www.marketresearchfuture.com/enquiry/5656

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.